- ISIN DE000A3ENQ51
- Country Deutschland
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
|
SCHOTT Pharma AG & Co. KGaA
/ Preliminary announcement on the disclosure of financial statements
SCHOTT Pharma AG & Co. KGaA hereby announces that the following financial reports shall be disclosed:
Report Type: Quarterly/ Interim statement within the 1st half-year Language: German Date of disclosure: February 29, 2024 Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/ Language: English Date of disclosure: February 29, 2024 Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/ Report Type: Quarterly/ Interim statement within the 2nd half-year Language: German Date of disclosure: August 29, 2024 Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/ Language: English Date of disclosure: August 29, 2024 Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/
26.02.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | SCHOTT Pharma AG & Co. KGaA |
| Hattenbergstraße 10 | |
| 55122 Mainz | |
| Germany |
| End of News | EQS News Service |